The India Cancer Immunotherapy Market is on the verge of a major transformation, with projections indicating a substantial increase in market value from USD 3.34 billion in 2018 to an anticipated USD 6.0 billion by 2035. This represents a compound annual growth rate (CAGR) of 4.995% from 2025 onward, highlighting the growing adoption of advanced treatment modalities in the country. As cancer...

The Cancer Immunotherapy Market is witnessing a remarkable surge, projected to reach approximately USD 125.93 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.99%. This growth trajectory is fueled by groundbreaking therapies that are gaining traction in the treatment landscape. Notably, the market was valued at USD 73.7 billion in 2024 and USD 77.38 billion in 2025,...